CD8 T_regs SQa-1shing transplant rejection

Nathan A Bracey¹, Jonathan S Maltzman^{2

3}

Affiliations

¹ Institute of Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA.
² Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
³ Geriatric Research and Education and Clinical Center, Veterans Administration Palo Alto Health Care System, Palo Alto, CA, USA.

Nathan A Bracey et al. Sci Immunol. 2023 Dec.

. 2023 Dec;8(90):eadn0644.

doi: 10.1126/sciimmunol.adn0644. Epub 2023 Dec 1.

Nathan A Bracey¹, Jonathan S Maltzman^{2

3}

¹ Institute of Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA.
² Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
³ Geriatric Research and Education and Clinical Center, Veterans Administration Palo Alto Health Care System, Palo Alto, CA, USA.

Abstract

MHC-E restricted CD8⁺ regulatory T cells have a restricted TCR repertoire and eliminate pathogenic CD4 T cells to mediate immune responses.